4.3 Article

Patients' perceptions of topical treatments of actinic keratosis

Journal

JOURNAL OF DERMATOLOGICAL TREATMENT
Volume 25, Issue 5, Pages 375-379

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.3109/09546634.2012.757285

Keywords

actinic keratosis; topical treatment; efficiency; pain; patient perspectives; interview

Categories

Funding

  1. LEO Pharma
  2. Astellas
  3. Basilea Pharma
  4. Pfizer

Ask authors/readers for more resources

Objectives: In recent years, a number of topical treatments suitable for field-directed therapy of actinic keratosis (AK) have been developed. Non-surgical treatment of AK however requires strict adherence by patients. Patients' views on the different possible topical treatments are therefore relevant to the choice of treatment. The aim of the study was to disclose the silent perspectives by focusing on user experiences and individual perspectives on topical treatment. Materials and methods: Telephone interviews and face-to-face interviews were conducted with patients having had treatment with one or more of the following: imiquimod 5%, diclofenac sodium gel 3%, 5-fluorouracil (5-FU) cream 5% or photodynamic therapy. Results: 24 patients with AK were interviewed. Experiences of pain, discharging ulcers and efficiency of the treatment were of major importance. There was a general focus on appearance, social contacts and leisure time, although this appeared to be of lesser importance. Patients' perception of treatment instructions identified a risk of misunderstandings. Conclusion: Patients are primarily concerned with therapeutic efficiency. Pain and ulcers are central indicators, but appearance, social contacts and leisure time can also be considered as additional indicators of satisfaction. A firm focus on patient instruction is suggested.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available